Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

What You Need to Know about the New Kaiser Poll

By Robert Zirkelbach  |    April 22, 2015
Spending on retail prescription medicines has consistently accounted for just 10 percent of health care spending, even though biopharmaceutical companies have brought more than 500 medicines to...   Read More

Medicare Monday: Gaining Part D Coverage Reduces Hospitalizations and Overall Spending in Medicare

By Allyson Funk  |    March 30, 2015
As you learned in last week’s video, Medicare Part D helps seniors adhere to their medicines by providing access to prescription drug coverage. This helps beneficiaries live healthier lives by...   Read More

The Five Essential Truths about Prescription Drug Spending

By Robert Zirkelbach  |    March 10, 2015
This blog post has been updated. Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail...   Read More

New Report: Forecasts for Specialty Medicines Have Been Overstated

By Jennifer Bryant  |    February 9, 2015
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...   Read More

Wanted: A Balanced Discussion on Health Care Costs

By Robert Zirkelbach  |    January 15, 2015
1-26-15 UPDATE: In response to the op-ed referenced below, The New York Times posted a Letter To The Editor from PhRMA President & CEO John Castellani.   Read More

Prescription Drug Lifecycle Helps Health Care Spending Hit Record Low

By Holly Campbell  |    December 5, 2014
Following several years of modest growth, a new study published in Health Affairs reports a record low health care spending increase of 3.6 percent in 2013. The last time the annual growth rate was...   Read More

Why Are Cancer Medicines Expensive?

By John Castellani  |    October 6, 2014
This post first appeared on the Morning Consult.  Prescription medicines account for just nine cents of every dollar spent on health care in the U.S., and cancer medicines represent just one percent...   Read More

What 60 Minutes Missed on the Value and Cost of Cancer Medicines

By Josephine Martin  |    October 5, 2014
The biopharmaceutical industry is proud of its track record of developing innovative medicines that have extended and improved the lives of patients suffering from cancer.   Read More

Five Facts About the Value of Innovative Cancer Medicines

By PhRMA Staff  |    May 14, 2014
There have been a lot of discussions lately about the value and cost of cancer medicines – it is also an issue that will be raised at the upcoming American Society of Clinical Oncology’s (ASCO)...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates